Papers in Surgical Oncology Insight
Page 2 · newest first
- Society of surgical oncology medical student & trainee primer for hepatopancreatobiliary surgical oncologySurgical Oncology Insight · 2025
- Society of surgical oncology medical student & trainee primer for skin, soft tissue, and endocrine surgical oncologySurgical Oncology Insight · 2025
- National trends in emergency and non-emergency colorectal cancer resections across the COVID-19 pandemicSurgical Oncology Insight · 2025
- The tumour microenvironment score outperforms established molecular classifiers as a prognostic factor for disease-free interval and disease-specific survival in non-metastatic gastric cancerSurgical Oncology Insight · 2025
- Intraoperative carcinoid crisis in NET operations – Eluding Dogma with current understandingSurgical Oncology Insight · 2025
- Neoadjuvant chemotherapy in patients ≥70 with node-positive triple negative breast cancerSurgical Oncology Insight · 2025
- Comparative survival analysis of gallbladder neuroendocrine carcinoma and adenocarcinoma following radical surgery: A secondary analysis of the multicenter Algerian GBC group studySurgical Oncology Insight · 2025
- Taiwan expert consensus on the clinical integration of antibody-drug conjugates in advanced breast cancerSurgical Oncology Insight · 2025
- HOXA13 overexpression is associated with poor prognosis in colorectal liver metastasesSurgical Oncology Insight · 2025
- The use of neoadjuvant immunotherapy may be associated with increased surgical complications In women with triple-negative breast cancerSurgical Oncology Insight · 2025
- Age and muscle measures predict benefit of surgery in locally-advanced adenocarcinoma of the esophagusSurgical Oncology Insight · 2025
- Supporting the PACT Act: Top cancers diagnosed in young veterans who deployed to Iraq and AfghanistanSurgical Oncology Insight · 2025
- Dissecting the PRADO (Personalized Response-driven ADjuvant cOmbination therapy) trial in melanoma for surgical oncologists; safety and feasibility of surgical de-escalation after neo-adjuvant immunotherapy for macroscopic stage III melanomaSurgical Oncology Insight · 2025
- A single arm, prospective, open label, multicenter study assessing the safety and effectiveness of SPY AGENT GREEN and SPY fluorescence imaging systems in the visualization of lymphatic vessels and lymph nodes during lymphatic mapping and sentinel lymph node biopsy in subjects with breast cancerSurgical Oncology Insight · 2025
- Littoral cell angioma unveiled: Exploring diagnosis, treatment, and malignant potentialSurgical Oncology Insight · 2025
- Current status of intraoperative radiation therapy in rectal cancer: A national cancer database analysisSurgical Oncology Insight · 2025
- Assessing the ability of Timed Up and Go and Modified Frailty Index-5 compared to Fried frailty index to objectively identify frail patients undergoing evaluation for surgerySurgical Oncology Insight · 2025
- Taiwan Expert Consensus on the appropriate treatment strategies for HER2-low breast cancerSurgical Oncology Insight · 2025
- Maximum stomach area on preoperative CT predicts delayed gastric emptying in palliative gastrojejunostomySurgical Oncology Insight · 2025
- Body composition and post-operative outcomes after minimally-invasive esophagectomySurgical Oncology Insight · 2025
- Pre-operative biomarkers may predict nodal status in pancreatic ductal adenocarcinomaSurgical Oncology Insight · 2025
- Characterization of ultrarare sarcomas in a high-volume referral center in Latin AmericaSurgical Oncology Insight · 2025
- Surgical cancer patients’ attitudes and beliefs about cannabis at a midwest comprehensive cancer centerSurgical Oncology Insight · 2025
- Advancements in the surgical management of pancreatic masses: A comprehensive reviewSurgical Oncology Insight · 2025
- Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burdenSurgical Oncology Insight · 2025
- Single versus multiagent chemotherapy for ampullary carcinoma: A propensity matched multivariate analysis of the NCDBSurgical Oncology Insight · 2025
- Association of neighborhood socioeconomic status and ethnic diversity with receipt of adjuvant chemotherapy in stage III colon cancer: A population-based cohort studySurgical Oncology Insight · 2025
- Collateral vessel formation affects long-term patency of artificial vessels: Insights from 60 cases of superior vena cava reconstruction combined with thymic tumor resectionSurgical Oncology Insight · 2025
- Survival in stage IV colorectal cancer at diagnosisSurgical Oncology Insight · 2025
- Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort studySurgical Oncology Insight · 2025
- Efficacy of Yttrium90 transarterial radioembolization as a bridge to surgery in hepatocellular carcinomaSurgical Oncology Insight · 2025
- From genes to glands: The genetic framework of parathyroid syndromesSurgical Oncology Insight · 2025
- DOTATATE PET CT tumor volume as a predictor of surgical outcome in patients with metastatic gastroenteropancreatic neuroendocrine tumorsSurgical Oncology Insight · 2025
- Liver resection that is less extensive than segmentectomy for hepatocellular carcinoma focused on the fourth branch of the portal veinSurgical Oncology Insight · 2025
- Propensity score–weighted analysis of neoadjuvant therapy versus upfront surgical resection in patients with biliary tract cancersSurgical Oncology Insight · 2025
- Multidisciplinary management of nonmetastatic locally advanced prostate cancer (T3-4N0M0)Surgical Oncology Insight · 2025
- Survival and morbidity following metastasectomy for stage IV melanoma in the era of systemic therapy: A multicenter retrospective cohort studySurgical Oncology Insight · 2025
- National disparity in guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosisSurgical Oncology Insight · 2025
- Impact of a technology enhanced breast multidisciplinary cancer conferenceSurgical Oncology Insight · 2025
- The evolving treatment for early-stage lung cancer: ImmunotherapySurgical Oncology Insight · 2025
- Starting a Hepato-Pancreato-Biliary surgery program from scratch: Closing the gap in West AfricaSurgical Oncology Insight · 2025
- A single institution experience using ultrasound-guided intralesional immunotherapy in recurrent melanomaSurgical Oncology Insight · 2025
- Society of surgical oncology medical student & trainee primer for breast surgical oncologySurgical Oncology Insight · 2025
- Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapySurgical Oncology Insight · 2025
- Hepatic and peri-hepatic cytoreductive surgery in low-grade appendiceal mucinous neoplasmsSurgical Oncology Insight · 2025
- Optimal surveillance for detecting sarcoma lung metastasis – A systematic reviewSurgical Oncology Insight · 2025
- Impact of clinicopathologic factors on the number of lymph nodes examined in patients with melanomaSurgical Oncology Insight · 2025
- Circulating tumor DNA predicts recurrence in patients receiving adjuvant hepatic artery infusion chemotherapy for resected colorectal liver metastasesSurgical Oncology Insight · 2025
- Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinomaSurgical Oncology Insight · 2024
- Prognostic impact of the CALLY index in patients with resectable pancreatic cancerSurgical Oncology Insight · 2024